Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer. [electronic resource]
Producer: 19940308Description: 2108-13 p. digitalISSN:- 0959-8049
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.